Golden Matrix Group Inc (GMGI)
4.20
+0.10
(+2.44%)
USD |
NASDAQ |
May 03, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Golden Matrix Group R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|---|
| July 31, 2021 | -- |
| April 30, 2021 | -- |
| Date | Value |
|---|---|
| January 31, 2021 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.